Dexterra Group (DXT) AGM 2024 summary
Event summary combining transcript, slides, and related documents.
AGM 2024 summary
2 Apr, 2026Opening remarks and agenda
Meeting held virtually with voting and Q&A facilitated online.
Chair and Secretary roles confirmed; scrutineers appointed to oversee voting.
Notice of meeting and quorum confirmed; meeting declared properly constituted.
Board and executive committee updates
Nine directors nominated and elected for the coming year.
CEO Mark Becker and CFO Denise Achonu present; executive team changes planned post-modular sale.
Management uses non-GAAP measures for performance evaluation and compensation.
Chief Financial Officer contact provided for investor relations.
Overview of voting outcomes
All items of business, including director elections and auditor appointment, approved by shareholders.
Final voting results to be filed on SEDAR and released via press release.
Latest events from Dexterra Group
- Record 2025 revenue, EBITDA growth, and acquisitions drove strong earnings and shareholder returns.DXT
Q4 20258 May 2026 - Q1 2026 revenue up 15% and adjusted EBITDA up 32%, with strong margins and positive outlook.DXT
Q1 20267 May 2026 - Record financials, all proposals approved, with focus on growth, M&A, and sustainability.DXT
AGM 20252 Apr 2026 - Strong 2025 performance, strategic acquisitions, and sustainability drive growth and returns.DXT
Corporate presentation1 Apr 2026 - Q2 2024 revenue grew 18.1% year-over-year, driven by WAFES and IFM gains, with higher margins.DXT
Q2 20241 Apr 2026 - Q3 revenue up 1.5% to $269.7M, strong IFM growth, Modular business sold, outlook robust.DXT
Q3 20241 Apr 2026 - Record 2024 revenue, margin gains, and strong cash flow conversion drive positive outlook.DXT
Q4 202425 Dec 2025 - Q1 2025 delivered 29% EBITDA growth, 15% ROE, and strong Support Services performance.DXT
Q1 202524 Nov 2025 - Strong Q2 results, $30M EBITDA, major acquisitions, and a 14% dividend hike boost outlook.DXT
Q2 202523 Nov 2025